1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Serotonin Antagonists 1.2.3 Steroids 1.2.4 Dopamine Antagonists 1.2.5 NK-1 Receptor Antagonists 1.2.6 Non-pharmacologic Treatment 1.2.7 Others 1.3 Market by Application 1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Retail Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2016-2027) 2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Regions 2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Share by Regions (2016-2021) 2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2022-2027) 2.3 Postoperative Nausea and Vomiting (PONV) Industry Dynamic 2.3.1 Postoperative Nausea and Vomiting (PONV) Market Trends 2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers 2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges 2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue 3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2016-2021) 3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2016-2021) 3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue 3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio 3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2020 3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served 3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service 3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type 4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2016-2021) 4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027) 5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application 5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2016-2021) 5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) 6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type 6.2.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) 6.2.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) 6.2.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027) 6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application 6.3.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) 6.3.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) 6.3.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027) 6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country 6.4.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) 6.4.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) 7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type 7.2.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) 7.2.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) 7.2.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027) 7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application 7.3.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) 7.3.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) 7.3.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027) 7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country 7.4.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) 7.4.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) 8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type 8.2.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027) 8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application 8.3.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027) 8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region 8.4.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) 9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type 9.2.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) 9.2.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) 9.2.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027) 9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application 9.3.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) 9.3.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) 9.3.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027) 9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country 9.4.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) 9.4.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) 10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type 10.2.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027) 10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application 10.3.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027) 10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country 10.4.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Acacia Pharma 11.1.1 Acacia Pharma Company Details 11.1.2 Acacia Pharma Business Overview 11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction 11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.1.5 Acacia Pharma Recent Development 11.2 F. Hoffmann-La Roche 11.2.1 F. Hoffmann-La Roche Company Details 11.2.2 F. Hoffmann-La Roche Business Overview 11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction 11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.2.5 F. Hoffmann-La Roche Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction 11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Ani Pharmaceuticals 11.4.1 Ani Pharmaceuticals Company Details 11.4.2 Ani Pharmaceuticals Business Overview 11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction 11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.4.5 Ani Pharmaceuticals Recent Development 11.5 Camurus 11.5.1 Camurus Company Details 11.5.2 Camurus Business Overview 11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction 11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.5.5 Camurus Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction 11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.6.5 Sanofi Recent Development 11.7 Helsinn Holding 11.7.1 Helsinn Holding Company Details 11.7.2 Helsinn Holding Business Overview 11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction 11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.7.5 Helsinn Holding Recent Development 11.8 Eisai 11.8.1 Eisai Company Details 11.8.2 Eisai Business Overview 11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction 11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.8.5 Eisai Recent Development 11.9 Merck 11.9.1 Merck Company Details 11.9.2 Merck Business Overview 11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction 11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.9.5 Merck Recent Development 11.10 GlaxoSmithKline 11.10.1 GlaxoSmithKline Company Details 11.10.2 GlaxoSmithKline Business Overview 11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction 11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) 11.10.5 GlaxoSmithKline Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Serotonin Antagonists Table 3. Key Players of Steroids Table 4. Key Players of Dopamine Antagonists Table 5. Key Players of NK-1 Receptor Antagonists Table 6. Key Players of Non-pharmacologic Treatment Table 7. Key Players of Others Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2016-2021) Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2022-2027) Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2016-2021) Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020) Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million) Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021) Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2016-2021) Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million) Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million) Table 38. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million) Table 65. Acacia Pharma Company Details Table 66. Acacia Pharma Business Overview Table 67. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Table 68. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 69. Acacia Pharma Recent Development Table 70. F. Hoffmann-La Roche Company Details Table 71. F. Hoffmann-La Roche Business Overview Table 72. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Table 73. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 74. F. Hoffmann-La Roche Recent Development Table 75. Novartis Company Details Table 76. Novartis Business Overview Table 77. Novartis Postoperative Nausea and Vomiting (PONV) Product Table 78. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 79. Novartis Recent Development Table 80. Ani Pharmaceuticals Company Details Table 81. Ani Pharmaceuticals Business Overview Table 82. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Table 83. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 84. Ani Pharmaceuticals Recent Development Table 85. Camurus Company Details Table 86. Camurus Business Overview Table 87. Camurus Postoperative Nausea and Vomiting (PONV) Product Table 88. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 89. Camurus Recent Development Table 90. Sanofi Company Details Table 91. Sanofi Business Overview Table 92. Sanofi Postoperative Nausea and Vomiting (PONV) Product Table 93. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 94. Sanofi Recent Development Table 95. Helsinn Holding Company Details Table 96. Helsinn Holding Business Overview Table 97. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Table 98. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 99. Helsinn Holding Recent Development Table 100. Eisai Company Details Table 101. Eisai Business Overview Table 102. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 103. Eisai Recent Development Table 104. Merck Company Details Table 105. Merck Business Overview Table 106. Merck Postoperative Nausea and Vomiting (PONV) Product Table 107. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 108. Merck Recent Development Table 109. GlaxoSmithKline Company Details Table 110. GlaxoSmithKline Business Overview Table 111. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Table 112. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million) Table 113. GlaxoSmithKline Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2020 VS 2027 Figure 2. Serotonin Antagonists Features Figure 3. Steroids Features Figure 4. Dopamine Antagonists Features Figure 5. NK-1 Receptor Antagonists Features Figure 6. Non-pharmacologic Treatment Features Figure 7. Others Features Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2020 VS 2027 Figure 9. Hospital Pharmacies Case Studies Figure 10. Online Pharmacies Case Studies Figure 11. Retail Pharmacies Case Studies Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions: 2020 VS 2027 Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2022-2027) Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2020 Figure 18. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2020 Figure 20. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021) Figure 21. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027) Figure 22. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027) Figure 24. North America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027) Figure 25. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027) Figure 26. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027) Figure 30. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027) Figure 31. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027) Figure 32. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027) Figure 40. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027) Figure 41. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2016-2027) Figure 42. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027) Figure 50. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027) Figure 51. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027) Figure 52. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027) Figure 56. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027) Figure 57. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027) Figure 58. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 64. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 65. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 66. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 67. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 68. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 69. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 70. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Acacia Pharma F. Hoffmann-La Roche Novartis Ani Pharmaceuticals Camurus Sanofi Helsinn Holding Eisai Merck GlaxoSmithKline